Text Size
2 studies found for:    22045986 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed Phase I/II CPG 7909 + Local XRT in Recurrent Low-Grade Lymphomas
Condition: Lymphoma, Non-Hodgkin
Intervention: Drug: CPG 7909
2 Withdrawn Phase I/II Study of Intratumoral Injection of CPG 7909, a TLR9 Agonist, Combined With Local Radiation for Patients With Recurrent Mycosis Fungoides.
Condition: Mycosis Fungoides
Intervention: Drug: CPG 7909
To Top

† Indicates status has not been verified in more than two years